SCHEMBL8792548

SCHEMBL8792548

CCCSn1cnc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.46
▸ ASAH1 Q13510 1/20 0.43
▸ HTT P42858 5/20 0.41
▸ LMNA P02545 4/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ CYP11B1 P15538 5/20 0.41
▸ CYP11B2 P19099 5/20 0.41
▸ TNF P01375 1/20 0.41
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ PKM P14618 1/20 0.39
▸ GGPS1 O95749 1/20 0.39
▸ FDPS P14324 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11140162 0.90 ASAH1 (0.47) TDP1ASAH1HTTLMNASMN1; SMN2
SCHEMBL9060998 0.86 TDP1 (0.48) TDP1ASAH1HTTLMNASMN1; SMN2
SCHEMBL6530090 0.83 TDP1 (0.46) TDP1HTTLMNASMN1; SMN2CYP11B1
SCHEMBL10735469 0.80 TDP1 (0.43) TDP1HTTLMNASMN1; SMN2TSHR
SCHEMBL29195662 0.80 ASAH1 (0.44) TDP1ASAH1HTTLMNASMN1; SMN2
SCHEMBL30846016 0.80 ASAH1 (0.44) TDP1ASAH1HTTLMNASMN1; SMN2
SCHEMBL11451311 0.79 TDP1 (0.46) TDP1HTTLMNASMN1; SMN2TSHR
SCHEMBL8413080 0.79 TDP1 (0.48) TDP1ASAH1HTTLMNASMN1; SMN2
SCHEMBL16401979 0.76 TDP1 (0.46) TDP1ASAH1HTTLMNASMN1; SMN2
SCHEMBL6529410 0.76 CYP11B1 (0.53) TDP1ASAH1HTTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018148224-A1 PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) 2018-08-16 — — WO claimed
US-20230172981-A1 METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST (US) 2023-06-08 — — US disclosed
US-20210317407-A1 METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS Seattle Children's Hospital (dba Seattle Children's Research Institute) 2021-10-14 — — US disclosed
WO-2018148224-A1 PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) 2018-08-16 — — WO disclosed
EP-0594726-B1 BENZIMIDAZOLE ANTHELMINTIC AGENTS PFIZER LTD (GB) 1997-01-29 — — EP disclosed
Send feedback